Icon (ICLR) Income from Non-Controlling Interests (2019 - 2020)
Icon (ICLR) posted quarterly Income from Non-Controlling Interests of $1.3 million for Q4 2020, up 248.24% year-over-year from $363538.7 in Q1 2020, and up 300.0% quarter-over-quarter from -$633000.0 in Q1 2020.
Icon (ICLR) Income from Non-Controlling Interests (2019 - 2020) Analysis & Trends
Icon (ICLR) has reported Income from Non-Controlling Interests for 2 consecutive years, with $1.3 million the latest figure, recorded in Q4 2020.
- In Q4 2020, Income from Non-Controlling Interests rose 248.24% year-over-year to $1.3 million; the TTM figure through Sep 2021 stood at $1.3 million (up 185.14% YoY), while the FY2020 annual figure was $633000.0, down 66.15% from the prior year.
- Income from Non-Controlling Interests grew to $1.3 million in Q4 2020 per ICLR's latest filing, from -$633000.0 in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at $1.3 million in Q4 2020 and bottomed at -$854000.0 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.78 Bn | 209.71 Bn | 8.34 Bn | 5.00 Mn |
| 2 | Danaher | 139.83 Bn | 135.48 Bn | 3.61 Bn | - |
| 3 | Idexx Laboratories | 45.99 Bn | 45.79 Bn | 779.09 Mn | - |
| 4 | Agilent Technologies | 39.69 Bn | 37.88 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 39.31 Bn | 37.23 Bn | 1.44 Bn | 2.00 Mn |
| 6 | Natera | 38.74 Bn | 37.64 Bn | 696.04 Mn | - |
| 7 | Illumina | 29.94 Bn | 28.77 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.55 Bn | 28.50 Bn | 650.22 Mn | - |
| 9 | Quest Diagnostics | 26.18 Bn | 25.55 Bn | 1.03 Bn | 14.00 Mn |
| 10 | Icon | 12.56 Bn | 12.56 Bn | 479.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 1.27 Mn |
| Mar 31, 2020 | -633,000.00 |
| Dec 31, 2019 | -854,000.00 |
| Sep 30, 2019 | -658,000.00 |
| Jun 30, 2019 | -358,000.00 |